The U.S. Food and Drug Administration has given green signal to Bristol-Myers Squibb Co for its drug that treats rare and potentially fatal disorders that involves loss of body fat. Myalept (metreleptin) has received FDA nod to be used as a replacement therapy for treating complications caused by leptin hormone deficiency in patients with congenital or acquired generalized lipodystrophy. The … [Read more...]
You are here: Home / Archives for Myalept